Fortress Biotech, Inc. insider trades: Checkpoint Therapeutics (CKPT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Fortress Biotech, Inc. reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 29, 2025 | CKPT | ↓ Sell | 100,000 | $1.29 | $129K | Direct | Jun 3, 2025 (5d) |
| Sep 8, 2023 | ATXI | ↑ Buy | 418,410 | $0.72 | $301K | Direct | Sep 12, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Fortress Biotech, Inc.'s insider trades
Fortress Biotech, Inc. is an insider at Checkpoint Therapeutics (CKPT). Since Sep 8, 2023, it has reported 1 open-market purchase worth $301K and 1 sale worth $129K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include grants and awards (27 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CKPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.